Knockdown of c-Jun resulted in decreased levels of PD-L1 in melanoma cells resistant to BRAF inhibitors [32], and co-activation of STAT3 and the subsequent formation of a transcriptional complex further enhanced these effects [95]. Here, JUN is linked to melanoma.